Description
Disease Indications
Progeria
Manufacturer
Usage
Subcutaneous
Medicine approved by
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Price range: $1,500.00 through $2,000.00
Skytrofa (lonapegsomatropin-tcgd) is a human growth hormone used once weekly for the treatment of pediatric growth hormone deficiency.
Disease Indications
Progeria
Manufacturer
Usage
Subcutaneous
Medicine approved by
European Medical Agency (EMA)
Food and Drug Administration (FDA)
| Package 4 prefilled cartridges with 6 disposable needles | 4 single-dose prefilled cartridges x 5.2 mg, 4 single-dose prefilled cartridges x 7.6 mg |
|---|
Reviews
There are no reviews yet.